Stock GIANLIFE GIAN LIFE CARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Gian Life Care Limited

Equities

GIANLIFE

INE063601012

Healthcare Facilities & Services

Market Closed - Bombay S.E.
Other stock markets
 06:00:54 2024-07-02 EDT 		5-day change 1st Jan Change
22.25 INR -0.89% Intraday chart for Gian Life Care Limited +7.13% +12.09%
05-30 Gian Life Care Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
01-13 Gian Life Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: March 2020 2021 2022
Capitalization 1 62.05 63.46 429.7
Enterprise Value (EV) 1 78 65.06 426.3
P/E ratio 4.22 x 3.15 x 9.83 x
Yield - - -
Capitalization / Revenue 0.81 x 0.61 x 2.7 x
EV / Revenue 1.02 x 0.62 x 2.68 x
EV / EBITDA 3.89 x 2.14 x 7.09 x
EV / FCF -3,474,766 x 3,101,778 x 20,794,621 x
FCF Yield -0% 0% 0%
Price to Book 0.68 x 0.66 x 3.06 x
Nbr of stocks (in thousands) 10,342 10,342 10,342
Reference price 2 6.000 6.136 41.55
Announcement Date 21-09-07 21-09-07 22-09-14
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022
Net sales 1 13.4 76.45 104.5 159.3
EBITDA 1 4.68 20.05 30.45 60.15
EBIT 1 4.193 17.57 27.66 56.95
Operating Margin 31.29% 22.97% 26.46% 35.75%
Earnings before Tax (EBT) 1 3.257 15.58 27.55 58.5
Net income 1 2.41 11.27 20.17 43.71
Net margin 17.98% 14.74% 19.29% 27.44%
EPS 2 0.3340 1.422 1.950 4.227
Free Cash Flow - -22.45 20.97 20.5
FCF margin - -29.36% 20.06% 12.87%
FCF Conversion (EBITDA) - - 68.89% 34.08%
FCF Conversion (Net income) - - 103.98% 46.9%
Dividend per Share - - - -
Announcement Date 19-07-08 21-09-07 21-09-07 22-09-14
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022
Net Debt 1 20.8 16 1.6 -
Net Cash position 1 - - - 3.35
Leverage (Debt/EBITDA) 4.436 x 0.7958 x 0.0525 x -
Free Cash Flow - -22.4 21 20.5
ROE (net income / shareholders' equity) - 29.1% 23.3% 36.9%
ROA (Net income/ Total Assets) - 10.9% 12.4% 18.5%
Assets 1 - 103.6 162.4 236.7
Book Value Per Share 2 0.2500 8.850 9.340 13.60
Cash Flow per Share 2 2.520 1.310 2.430 4.690
Capex 1 70.3 1.87 4.33 9.57
Capex / Sales 524.63% 2.44% 4.14% 6.01%
Announcement Date 19-07-08 21-09-07 21-09-07 22-09-14
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
GIAN LIFE CARE LIMITED Stock Gian Life Care Limited
+12.09% 2.78M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-20.36% 8.2B
RADNET, INC. Stock RadNet, Inc.
+69.89% 4.33B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
+7.87% 2.82B
SYNLAB AG Stock SYNLAB AG
-2.98% 2.64B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-13.26% 1.78B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-57.71% 1.74B
FLEURY S.A. Stock Fleury S.A.
-15.91% 1.5B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+19.97% 1.26B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-50.19% 1.01B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. GIANLIFE Stock
  4. Financials Gian Life Care Limited